
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current MREO market cap is 387.86M. The company's latest EPS is USD -0.2788 and P/E is -9.00.
Quarter End | |||||
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | USD (US$) | |
Total Revenue | |||||
Operating Income | |||||
Net Income |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | USD (US$) | |
Total Revenue | 0 | 36.46M | 0 | 7.91M | 0 |
Operating Income | -37.57M | -20.94M | -43.57M | -32.97M | -45.72M |
Net Income | -163.63M | 12.73M | -33.24M | -33.18M | -43.25M |
Quarter End | |||||
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | USD (US$) | |
Total Assets | |||||
Total Liabilities | |||||
Total Equity |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | USD (US$) | |
Total Assets | 62.95M | 126.42M | 84.12M | 62.5M | 76.39M |
Total Liabilities | 77.92M | 38.42M | 21.58M | 13.19M | 15.42M |
Total Equity | -14.97M | 88M | 62.54M | 49.31M | 60.97M |
Quarter End | |||||
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | USD (US$) | |
Operating | |||||
Investing | |||||
Financing |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | USD (US$) | |
Operating | -28.34M | -5.24M | -38.82M | -17.63M | -32.83M |
Investing | 1.5M | -421k | 1.5M | 1.29M | -699k |
Financing | 34.74M | 77.65M | -784k | 5.09M | 46.15M |
Market Cap | 387.86M |
Price to Earnings Ratio | -9.00 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 5.58 |
Price to Book Ratio | 6.39 |
Dividend Yield | - |
Shares Outstanding | 155.15M |
Average Volume (1 week) | 2.73M |
Average Volume (1 Month) | 1.99M |
52 Week Change | -6.54% |
52 Week High | 5.02 |
52 Week Low | 1.575 |
Spread (Intraday) | 0.23 (9.2%) |
Company Name | Mereo BioPharma Group PLC |
Address |
fourth floor london W1G 0QF |
Website | https://www.mereobiopharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions